Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading From the International Study Group for Pancreatic Surgery (ISGPS).


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 Apr 2022
Historique:
pubmed: 2 10 2021
medline: 27 4 2022
entrez: 1 10 2021
Statut: ppublish

Résumé

The ISGPS aimed to develop a universally accepted definition for PPAP for standardized reporting and outcome comparison. PPAP is an increasingly recognized complication after partial pancreatic resections, but its incidence and clinical impact, and even its existence are variable because an internationally accepted consensus definition and grading system are lacking. The ISGPS developed a consensus definition and grading of PPAP with its members after an evidence review and after a series of discussions and multiple revisions from April 2020 to May 2021. We defined PPAP as an acute inflammatory condition of the pancreatic remnant beginning within the first 3 postoperative days after a partial pancreatic resection. The diagnosis requires (1) a sustained postoperative serum hyperamylasemia (POH) greater than the institutional upper limit of normal for at least the first 48 hours postoperatively, (2) associated with clinically relevant features, and (3) radiologic alterations consistent with PPAP. Three different PPAP grades were defined based on the clinical impact: (1) grade postoperative hyperamylasemia, biochemical changes only; (2) grade B, mild or moderate complications; and (3) grade C, severe life-threatening complications. The present definition and grading scale of PPAP, based on biochemical, radiologic, and clinical criteria, are instrumental for a better understanding of PPAP and the spectrum of postoperative complications related to this emerging entity. The current terminology will serve as a reference point for standard assessment and lend itself to developing specific treatments and prevention strategies.

Sections du résumé

OBJECTIVE OBJECTIVE
The ISGPS aimed to develop a universally accepted definition for PPAP for standardized reporting and outcome comparison.
BACKGROUND BACKGROUND
PPAP is an increasingly recognized complication after partial pancreatic resections, but its incidence and clinical impact, and even its existence are variable because an internationally accepted consensus definition and grading system are lacking.
METHODS METHODS
The ISGPS developed a consensus definition and grading of PPAP with its members after an evidence review and after a series of discussions and multiple revisions from April 2020 to May 2021.
RESULTS RESULTS
We defined PPAP as an acute inflammatory condition of the pancreatic remnant beginning within the first 3 postoperative days after a partial pancreatic resection. The diagnosis requires (1) a sustained postoperative serum hyperamylasemia (POH) greater than the institutional upper limit of normal for at least the first 48 hours postoperatively, (2) associated with clinically relevant features, and (3) radiologic alterations consistent with PPAP. Three different PPAP grades were defined based on the clinical impact: (1) grade postoperative hyperamylasemia, biochemical changes only; (2) grade B, mild or moderate complications; and (3) grade C, severe life-threatening complications.
DISCUSSIONS CONCLUSIONS
The present definition and grading scale of PPAP, based on biochemical, radiologic, and clinical criteria, are instrumental for a better understanding of PPAP and the spectrum of postoperative complications related to this emerging entity. The current terminology will serve as a reference point for standard assessment and lend itself to developing specific treatments and prevention strategies.

Identifiants

pubmed: 34596077
doi: 10.1097/SLA.0000000000005226
pii: 00000658-202204000-00009
doi:

Substances chimiques

Propylamines 0
N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane 131903-56-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-672

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Bacchini I, Mantovani R, Viti M, et al. Study of postoperative amylasemia. Its diagnostic value in postoperative acute pancreatitis (PAP). Minerva Chir 1980; 35:429–438.
Matsusue S, Takeda H, Nakamura Y, et al. A prospective analysis of the factors influencing pancreaticojejunostomy performed using a single method, in 100 consecutive pancreaticoduodenectomies. Surg Today 1998; 28:719–726.
Kelly TR, Troyer ML. Pancreatic ducts and postoperative pancreatitis. Arch Surg 1963; 87:614–618.
Cloyd JM, Kastenberg ZJ, Visser BC, et al. Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. J Gastrointest Surg 2014; 18:348–353.
Okabayashi T, Kobayashi M, Nishimori I, et al. Risk factors, predictors and prevention of pancreatic fistula formation after pancreatoduodenectomy. J Hepatobiliary Pancreat Surg 2007; 14:557–563.
Palani Velu LK, Chandrabalan VV, Jabbar S, et al. Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy. HPB (Oxford) 2014; 16:610–619.
Lermite E, Pessaux P, Brehant O, et al. Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 2007; 204:588–596.
El Nakeeb A, Salah T, Sultan A, et al. Pancreatic anastomotic leakage after pancreaticoduodenectomy. Risk factors, clinical predictors, and management (single center experience). World J Surg 2013; 37:1405–1418.
Connor S. Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection. HPB (Oxford) 2016; 18:642–651.
Chen H, Wang W, Ying X, et al. Predictive factors for postoperative pancreatitis after pancreaticoduodenectomy: A single-center retrospective analysis of 1465 patients. Pancreatology 2020; 20:211–216.
Globke B, Timmermann L, Klein F, et al. Postoperative acute necrotizing pancreatitis of the pancreatic remnant (POANP): a new definition of severe pancreatitis following pancreaticoduodenectomy. HPB (Oxford) 2020; 22:445–451.
Nahm CB, Brown KM, Townend PJ, et al. Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula. HPB (Oxford) 2018; 20:432–440.
Kühlbrey CM, Samiei N, Sick O, et al. Pancreatitis after pancreatoduodenectomy predicts clinically relevant postoperative pancreatic fistula. J Gastrointest Surg 2017; 21:330–338.
Loos M, Strobel O, Dietrich M, et al. Hyperamylasemia and acute pancreatitis after pancreatoduodenectomy: two different entities. Surgery 2021; 169:369–376.
Partelli S, Tamburrino D, Andreasi V, et al. Implications of increased serum amylase after pancreaticoduodenectomy: toward a better definition of clinically relevant postoperative acute pancreatitis. HPB (Oxford) 2020; 22:1645–1653.
Zimmitti G, Langella S, Sega V, et al. Serum amylase elevation following pancreatoduodenectomy with pancreatogastrostomy is strongly associated with major complications. ANZ J Surg 2021; 91:348–354.
Ikenaga N, Ohtsuka T, Nakata K, et al. Clinical significance of postoperative acute pancreatitis after pancreatoduodenectomy and distal pancreatectomy. Surgery 2021; 169:732–737.
Bannone E, Andrianello S, Marchegiani G, et al. Postoperative acute pancreatitis following pancreaticoduodenectomy: a determinant of fistula potentially driven by the intraoperative fluid management. Ann Surg 2018; 268:815–822.
Bannone E, Andrianello S, Marchegiani G, et al. Postoperative hyperamylasemia (POH) and acute pancreatitis after pancreatoduodenectomy (POAP): state of the art and systematic review. Surgery 2021; 169:377–387.
Wüster C, Shi H, Kühlbrey CM, et al. Pancreatic inflammation and proenzyme activation are associated with clinically relevant postoperative pancreatic fistulas after pancreas resection. Ann Surg 2020; 272:863–870.
Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138:8–13.
Borchardt RA, Tzizik D. Update on surgical site infections: the new CDC guidelines. JAAPA 2018; 31:52–54.
Andrianello S, Bannone E, Marchegiani G, et al. Characterization of postoperative acute pancreatitis (POAP) after distal pancreatectomy. Surgery 2021; 169:724–731.
Birgin E, Reeg A, Téoule P, et al. Early postoperative pancreatitis following pancreaticoduodenectomy: what is clinically relevant postoperative pancreatitis? HPB (Oxford) 2019; 21:972–980.
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis – 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62:102–111.
Bassi C, Molinari E, Malleo G, et al. Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg 2010; 252:207–214.
Molinari E, Bassi C, Salvia R, et al. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg 2007; 246:281–287.
Jin S, Shi X-J, Sun X-D, et al. The gastric/pancreatic amylase ratio predicts postoperative pancreatic fistula with high sensitivity and specificity. Medicine (Baltimore) 2015; 94:e339.
Räty S, Sand J, Lantto E, et al. Postoperative acute pancreatitis as a major determinant of postoperative delayed gastric emptying after pancreaticoduodenectomy. J Gastrointest Surg 2006; 10:1131–1139.
Bruno O, Brancatelli G, Sauvanet A, et al. Utility of CT in the diagnosis of pancreatic fistula after pancreaticoduodenectomy in patients with soft pancreas. AJR Am J Roentgenol 2009; 193:W175–180.
Loos M, Strobel O, Mehrabi A, et al. Postoperative acute pancreatitis is a serious but rare complication after distal pancreatectomy. HPB 2021; 23:1339–1348.
Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017; 161:584–591.
Besselink MG, van Rijssen LB, Bassi C, et al. Definition and classification of chyle leak after pancreatic operation: a consensus statement by the International Study Group on Pancreatic Surgery. Surgery 2017; 161:365–372.
Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007; 142:20–25.
Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142:761–768.
Räty S, Sand J, Nordback I. Detection of postoperative pancreatitis after pancreatic surgery by urine trypsinogen strip test. Br J Surg 2007; 94:64–69.
Rudis J, Ryska M. Pancreatic leakage and acute postoperative pancreatitis after proximal pancreatoduodenectomy. Rozhl Chir 2014; 93:380–385.
Jin S, Shi X-J, Wang S-Y, et al. Drainage fluid and serum amylase levels accurately predict development of postoperative pancreatic fistula. World J Gastroenterol 2017; 23:6357–6364.
Malleo G, Salvia R, Butturini G, et al. Is routine imaging necessary after pancreatic resection? An appraisal of postoperative ultrasonography for the detection of pancreatic fistula. Pancreas 2014; 43:319–323.
Okano K, Kakinoki K, Suto H, et al. Persisting ratio of total amylase output in drain fluid can predict postoperative clinical pancreatic fistula. J Hepatobiliary Pancreat Sci 2011; 18:815–820.
Bannone E, Marchegiani G, Balduzzi A, et al. Early and sustained elevation in serum pancreatic amylase activity: a novel predictor of morbidity after pancreatic surgery. Ann Surg 2021; doi: 10.1097/SLA.0000000000004921.
doi: 10.1097/SLA.0000000000004921
Yoo D, Park SY, Hwang DW, et al. Lack of association between postoperative pancreatitis and other postoperative complications following pancreaticoduodenectomy. J Clin Med 2021; 10:1179.
Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg 2011; 253:879–885.
Zyromski NJ. Postpancreatectomy acute pancreatitis: Fact? Fiction? Functional definition and future. Surgery 2021; 169:738–739.
Andrianello S, Marchegiani G, Bannone E, et al. Clinical implications of intraoperative fluid therapy in pancreatic surgery. J Gastrointest Surg 2018; 22:2072–2079.
Svensson LG, Decker G, Kinsley RB. A prospective study of hyperamylasemia and pancreatitis after cardiopulmonary bypass. Ann Thorac Surg 1985; 39:409–411.
Feng F, Tan H, Li X, et al. Incidence and risk factors of acute pancreatitis after scoliosis surgery: a prospective study. Spine (Phila Pa 1976) 2018; 43:630–636.
Elgharably H, Gamaleldin M, Ayyat KS, et al. Serious gastrointestinal complications after cardiac surgery & associated mortality. Ann Thorac Surg 2021; 112:1266–1274.
Yen H-H, Ho T-W, Wu C-H, et al. Late acute pancreatitis after pancreaticoduodenectomy: incidence, outcome, and risk factors. J Hepato Biliary Pancreat Sci 2019; 26:109–116.
Demirjian AN, Kent TS, Callery MP, et al. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures. HPB 2010; 12:482–487.
Chen CB, McCall NS, Pucci MJ, et al. The combination of pancreas texture and postoperative serum amylase in predicting pancreatic fistula risk. Am Surg 2018; 84:889–896.
Barreto G, D'Souza MA, Shukla PJ, et al. The gray zone between postpancreaticoduodenectomy collections and pancreatic fistula. Pancreas 2008; 37:422–425.
Mortele KJ, Wiesner W, Intriere L, et al. A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. AJR Am J Roentgenol 2004; 183:1261–1265.
Winter JM, Cameron JL, Yeo CJ, et al. Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2007; 204:1029–1036.
Lambden S, Laterre PF, Levy MM, et al. The SOFA score—development, utility and challenges of accurate assessment in clinical trials. Crit Care 2019; 23:374.
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707–710.
Pulvirenti A, Marchegiani G, Pea A, et al. Clinical implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 consecutive pancreatic resections. Ann Surg 2018; 268:1069–1075.
Hong W, Geng W, Chen B, et al. Predictors of acute pancreatitis with low elevation of serum amylase. Therap Clin Risk Manag 2017; 13:1577.
Andrianello S, Marchegiani G, Malleo G, et al. Pancreaticojejunostomy with externalized stent vs pancreaticogastrostomy with externalized stent for patients with high-risk pancreatic anastomosis: a single-center, phase 3, randomized clinical trial. JAMA Surg 2020; 155:313–321.
Gasteiger S, Primavesi F, Göbel G, et al. Early post-operative pancreatitis and systemic inflammatory response assessed by serum lipase and IL-6 predict pancreatic fistula. World J Surg 2020; 44:4236–4244.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018; 9doi: 10. 3389/fimmu. 2018. 00754.
Laaninen M, Bläuer M, Sand J, et al. Difference in early activation of NF-(B and MCP-1 in acinar-cell-rich versus fibrotic human pancreas exposed to surgical trauma and hypoxia. Gastroenterol Res Pract 2014; 2014:460363.
Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg 2006; 93:518–530.
Laaninen M, Bläuer M, Vasama K, et al. The risk for immediate postoperative complications after pancreaticoduodenectomy is increased by high frequency of acinar cells and decreased by prevalent fibrosis of the cut edge of pancreas. Pancreas 2012; 41:957–961.
Partelli S, Andreasi V, Schiavo Lena M, et al. The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy. Surgery 2021; 170:1215–1222.
Shrikhande SV. Invited commentary: evolving landscape of postoperative hyperamylasemia, postoperative acute pancreatitis, and postoperative pancreatic fistula: time for a unifying definition. Surgery 2021; 169:740–741.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205–213.
Lassen K, Coolsen MME, Slim K, et al. Guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS®) society recommendations. Clin Nutr 2012; 31:817–830.
Laukkarinen J. Commentary on: postoperative acute pancreatitis. Surgery 2021; 169:742–743.
Salvia R, Marchegiani G, Andrianello S, et al. Redefining the role of drain amylase value for a risk-based drain management after pancreaticoduodenectomy: early drain removal still is beneficial. J Gastrointest Surg 2021; 25:1461–1470.
Andrianello S, Marchegiani G, Balduzzi A, et al. Pros and pitfalls of externalized trans-anastomotic stent as a mitigation strategy of POPF: a prospective risk-stratified observational series. HPB (Oxford) 2021; 23:1046–1053.
Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128:586–590.
Uemura K, Murakami Y, Hayashidani Y, et al. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy. J Surg Oncol 2008; 98:309–313.

Auteurs

Giovanni Marchegiani (G)

Department of Surgery, The Pancreas Institute, Verona University Hospital, Verona, Italy.

Savio George Barreto (SG)

Division of Surgery and Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia.

Elisa Bannone (E)

Department of Surgery, The Pancreas Institute, Verona University Hospital, Verona, Italy.

Michael Sarr (M)

Mayo Clinic Department of General Surgery, Rochester, NY.

Charles M Vollmer (CM)

Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Saxon Connor (S)

Department of Surgery, Christchurch Hospital, Christchurch, New Zealand.

Massimo Falconi (M)

Pancreatic Surgery Unit, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, "Vita-Salute" University, Milan, Italy.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Roberto Salvia (R)

Department of Surgery, The Pancreas Institute, Verona University Hospital, Verona, Italy.

Christopher L Wolfgang (CL)

Department of Surgery, NYU Grossman School of Medicine, New York, NY.

Nicholas J Zyromski (NJ)

Indiana University School of Medicine, Indiana University Health, Indianapolis, IN.

Charles J Yeo (CJ)

Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, PA.

Mustapha Adham (M)

Digestive Surgery Department, Lyon Civil Hospital, Lyon, France.

Ajith K Siriwardena (AK)

Manchester Royal Infirmary, Manchester, UK.

Kyoichi Takaori (K)

Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Mohammad Abu Hilal (MA)

Department of Surgery, Fondazione Poliambulanza, Brescia, Italy.

Martin Loos (M)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Pascal Probst (P)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Thilo Hackert (T)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Oliver Strobel (O)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Olivier R C Busch (ORC)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Keith D Lillemoe (KD)

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Yi Miao (Y)

Pancreas Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, PR China.

Christopher M Halloran (CM)

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

Jens Werner (J)

Department of General, Visceral, and Transplantation Surgery, Ludwig Maximilians-University, Munich, Germany.

Helmut Friess (H)

Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany.

Jakob R Izbicki (JR)

Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Maximillian Bockhorn (M)

Asklepios Harzklinik, Goslar, Germany.

Yogesh K Vashist (YK)

Professorial Surgical Unit, University of Dublin, Trinity College, Dublin, Ireland.

Kevin Conlon (K)

Department of Surgery, AGIA OLGA Hospital, Athens, Greece.

Ioannis Passas (I)

School of Medicine and Surgery, Milano - Bicocca University, and Department of Surgery, San Gerardo Hospital, Monza, Italy.

Luca Gianotti (L)

Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO.

Marco Del Chiaro (M)

Department of Surgery, Humanitas University and Research Hospital IRCCS, Milan, Italy.

Richard D Schulick (RD)

The Petz Aladar Hospital, Gyor, Hungary.

Marco Montorsi (M)

Department of HPB Surgery and Liver Transplant, Royal Free Hospital NHS Foundation Trust, London, UK.

Attila Oláh (A)

Department of Surgery, Miguel Servet University Hospital, Paseo Isabel la Catolica, Zaragoza, Spain.

Giuseppe Kito Fusai (GK)

University of Graz Hospital, Surgical Research Unit, Graz, Austria.

Alejandro Serrablo (A)

Department of Surgery, Clinical Sciences Lund, Lund University, Lund, Sweden.

Alessandro Zerbi (A)

Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO.

Abe Fingerhut (A)

Department of Gastrointestinal and HPB Surgical Oncology, Tata Memorial Hospital, Mumbai, India.

Roland Andersson (R)

The Petz Aladar Hospital, Gyor, Hungary.

Robert Padbury (R)

Division of Surgery and Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia.

Christos Dervenis (C)

Department of Surgery, AGIA OLGA Hospital, Athens, Greece.

John P Neoptolemos (JP)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Claudio Bassi (C)

Department of Surgery, The Pancreas Institute, Verona University Hospital, Verona, Italy.

Markus W Büchler (MW)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Shailesh V Shrikhande (SV)

Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH